SCHEMBL633799

SCHEMBL633799

NC1CCCNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1095429 1.00
SCHEMBL1095061 1.00
Hydrochloric Acid SCHEMBL2113214 0.98
Hydrochloric Acid SCHEMBL6067784 0.98 L3MBTL1 (0.41)
Hydrochloric Acid SCHEMBL3224238 0.98
Hydrochloric Acid SCHEMBL1066405 0.98
SCHEMBL1927815 0.93
SCHEMBL1114446 0.93
SCHEMBL56745 0.93
Hydrochloric Acid SCHEMBL1114699 0.91 CCR2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 646 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO claimed
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-24 US claimed
EP-4679086-A1 BIOMARKER AND USE THEREOF MEIJI CO., LTD (JP) 2026-01-14 EP claimed
CN-119517408-A Method for establishing death prediction model of new-onset type 2 diabetes and application 中南大学湘雅二医院 2025-02-25 CN claimed
CN-119432383-A High-selectivity etching solution for radio frequency chip material 湖北兴福电子材料股份有限公司 2025-02-14 CN claimed
CN-119371654-A Amino lactam and sugar lactone modified lactide high polymer and preparation method thereof 中鼎凯瑞科技成都有限公司 2025-01-28 CN claimed
US-20240400468-A1 Bionutritional Compositions for Plants and Soils ENVIROKURE, INCORPORATED (US) 2024-12-05 US claimed
EP-4457513-A1 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE Société des Produits Nestlé S.A. (CH) 2024-11-06 EP claimed
EP-3053972-B1 PENETRANT LIQUID FOR INK JET TEXTILE PRINTING SEIKO EPSON CORP (JP) 2024-08-21 EP claimed
CN-118435054-A Compositions and methods for diagnosing and treating chronic kidney disease 雀巢产品有限公司 2024-08-02 CN claimed
US-20150329538-A1 AMIDES AS PIM INHIBITORS AMGEN INC. (US) 2015-11-19 US claimed
US-9127044-B2 Cyclic depsipeptides NOVARTIS AG (CH) 2015-09-08 US claimed
WO-2013130660-A1 AMIDES AS PIM INHIBITORS AMGEN INC. (US) 2013-09-06 WO claimed
US-8415305-B2 Use of cyclic depsipeptides to inhibit kallikrein 7 NOVARTIS AG (CH) 2013-04-09 US claimed
US-20120196790-A1 CYCLIC DEPSIPEPTIDES NOVARTIS AG (CH) 2012-08-02 US claimed
US-8178650-B2 Cyclic depsipeptides NOVARTIS AG (CH) 2012-05-15 US claimed
EP-2183273-A1 CYCLIC DEPSIPEPTIDES Novartis Ag (CH) 2010-05-12 EP claimed
US-20100029941-A1 PREPARATION OF (R)-3-AMINOPIPERIDINE DIHYDROCHLORIDE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-04 US claimed
US-20090156472-A1 Cyclic Depsipeptides NOVARTIS AG (CH) 2009-06-18 US claimed
WO-2009024527-A1 CYCLIC DEPSIPEPTIDES NOVARTIS AG (CH) 2009-02-26 WO claimed